Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Purpura, Thrombotic Thrombocytopenic 1

Interventions

pembrolizumab 30 Cisplatin 20 Carboplatin 20 Paclitaxel 18 Dexamethasone 15 Pemetrexed 13 Nivolumab 13 Ipilimumab 12 Fluorouracil 11 Cyclophosphamide 11 Gemcitabine 10 Trastuzumab 9 Docetaxel 9 Cytarabine 9 daratumumab 8 atezolizumab 8 Rituximab 8 Capecitabine 8 Lenalidomide 7 Doxorubicin 7 zanubrutinib 6 Prednisone 6 Daunorubicin 6 Bortezomib 6 venetoclax 5 trametinib 5 nilotinib 5 ibrutinib 5 fludarabine 5 dabrafenib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Has announcements × caplacizumab × Clear all

NCT02553317 2023-04-05

HERCULES

Sanofi

Phase 3 Completed

145 enrolled 20 charts 1 FDA

Purpura, Thrombotic Thrombocytopenic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡